Correlation Between Ultimus Managers and IShares Biotechnology
Can any of the company-specific risk be diversified away by investing in both Ultimus Managers and IShares Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultimus Managers and IShares Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ultimus Managers Trust and iShares Biotechnology ETF, you can compare the effects of market volatilities on Ultimus Managers and IShares Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultimus Managers with a short position of IShares Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultimus Managers and IShares Biotechnology.
Diversification Opportunities for Ultimus Managers and IShares Biotechnology
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Ultimus and IShares is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Ultimus Managers Trust and iShares Biotechnology ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Biotechnology ETF and Ultimus Managers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultimus Managers Trust are associated (or correlated) with IShares Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Biotechnology ETF has no effect on the direction of Ultimus Managers i.e., Ultimus Managers and IShares Biotechnology go up and down completely randomly.
Pair Corralation between Ultimus Managers and IShares Biotechnology
Given the investment horizon of 90 days Ultimus Managers Trust is expected to generate 0.54 times more return on investment than IShares Biotechnology. However, Ultimus Managers Trust is 1.87 times less risky than IShares Biotechnology. It trades about 0.4 of its potential returns per unit of risk. iShares Biotechnology ETF is currently generating about -0.01 per unit of risk. If you would invest 2,587 in Ultimus Managers Trust on August 31, 2024 and sell it today you would earn a total of 196.00 from holding Ultimus Managers Trust or generate 7.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ultimus Managers Trust vs. iShares Biotechnology ETF
Performance |
| Timeline |
| Ultimus Managers Trust |
| iShares Biotechnology ETF |
Ultimus Managers and IShares Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ultimus Managers and IShares Biotechnology
The main advantage of trading using opposite Ultimus Managers and IShares Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultimus Managers position performs unexpectedly, IShares Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Biotechnology will offset losses from the drop in IShares Biotechnology's long position.| Ultimus Managers vs. First Trust North | Ultimus Managers vs. Global X MLP | Ultimus Managers vs. Global X MLP | Ultimus Managers vs. Tortoise North American |
| IShares Biotechnology vs. First Trust Exchange Traded | IShares Biotechnology vs. Ultimus Managers Trust | IShares Biotechnology vs. Horizon Kinetics Medical | IShares Biotechnology vs. Harbor Health Care |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |